Compare Liquidia Corporation Common Stock (LQDA) vs Tesla, Inc. (TSLA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Liquidia Corporation Common Stock vs Tesla, Inc. — how do they compare? Liquidia Corporation Common Stock trades at $33.47 (market cap $3.04B), while Tesla, Inc. trades at $361.77 (market cap $1.45T). The key difference: Tesla, Inc. is far larger — about 477× Liquidia Corporation Common Stock's market cap, and Tesla, Inc. is trading nearer its 52-week high, Liquidia Corporation Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Liquidia Corporation Common Stock for 0 Days and Tesla, Inc. for 88 Days on average.
| LQDA | TSLA | |
|---|---|---|
Market Cap | $3.04B | $1.45T |
Volume | 21,111,778 | 30,868,569 |
Sector | Health | Consumer Cyclical |
52-Week High | $91.03 | $489.88 |
52-Week Low | $22.02 | $298.16 |
Typical Hold Time | 0 Days | 88 Days |
Enterprise Value | $2.94B | $1.42T |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Tesla (TSLA) trades at $375.20, down 0.75% on the day amid mixed signals. The stock shows a bullish technical trend with strong moving averages but faces overbought RSI warnings. Fundamentally, revenue dipped to $94.83B in 2025 with net income margin at 3.67%, while valuation ratios remain elevated with a P/E of 339.96. Recent news highlights regulatory approval for self-driving software in Europe and a potential cheaper EV launch, balancing delivery misses and competitive pressures.
Tesla's outlook hinges on executing its pivot to AI and autonomy, with a consensus price target of $441.36 offering 18% upside. However, high valuations, slowing auto growth, and execution risks in new ventures pose significant challenges. Investors should weigh the long-term potential of robotaxis and energy against near-term profitability concerns and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Liquidia Corporation Common Stock
Liquidia Corporation is a biopharmaceutical company that develops therapies for rare cardiopulmonary diseases, including YUTREPIA, an inhaled treprostinil powder for pulmonary hypertension built on its PRINT technology.
Read more on LQDA →About Tesla, Inc.
Tesla Inc. designs, manufactures, and sells high-performance electric vehicles and electric vehicle powertrain components. The Company owns its sales and service network and sells electric power train components to other automobile manufacturers. Tesla serves customers worldwide.
Read more on TSLA →
